All terms in GO
| Label | Id | Description |
|---|---|---|
| positive regulation of vascular permeability | GO_0043117 |
Any process that increases the extent to which blood vessels can be pervaded by fluid.
|
| positive regulation of receptor-mediated endocytosis involved in cholesterol transport | GO_1905602 |
Any process that activates or increases the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
|
| positive regulation of intracellular cholesterol transport | GO_0032385 |
Any process that activates or increases the frequency, rate or extent of the directed movement of cholesterol within cells.
|
| obsolete inositol hexakisphosphate 1-kinase or 3-kinase activity | GO_0070190 |
OBSOLETE. Catalysis of the reaction: ATP + 1D-myo-inositol hexakisphosphate = ADP + 1-diphospho-1D-myo-inositol (2,3,4,5,6)pentakisphosphate, and ATP + 1D-myo-inositol hexakisphosphate = ADP + 3-diphospho-1D-myo-inositol (1,2,4,5,6)pentakisphosphate.
|
| regulation of presynapse assembly | GO_1905606 |
Any process that modulates the frequency, rate or extent of presynapse assembly.
|
| methionine-R-sulfoxide reductase activity | GO_0070191 |
Catalysis of the reaction: L-methionine R-oxide + thioredoxin = L-methionine + thioredoxin disulfide; can act on free oxidized methionine with specificity for the R enantiomer; does not act on oxidized methionine in peptide linkage. Thioredoxin disulfide is the oxidized form of thioredoxin.
|
| positive regulation of smooth muscle cell-matrix adhesion | GO_1905609 |
Any process that activates or increases the frequency, rate or extent of smooth muscle cell-matrix adhesion.
|
| positive regulation of cell-matrix adhesion | GO_0001954 |
Any process that activates or increases the rate or extent of cell adhesion to an extracellular matrix.
|
| regulation of synapse assembly | GO_0051963 |
Any process that modulates the frequency, rate or extent of synapse assembly, the aggregation, arrangement and bonding together of a set of components to form a synapse.
|
| synaptonemal complex organization | GO_0070193 |
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a synaptonemal complex. A synaptonemal complex is a proteinaceous scaffold formed between homologous chromosomes during meiosis.
|
| synaptonemal complex disassembly | GO_0070194 |
The controlled breakdown of a synaptonemal complex.
|
| growth hormone receptor complex | GO_0070195 |
A receptor complex that consists of two identical subunits and binds growth hormone.
|
| eukaryotic translation initiation factor 3 complex assembly | GO_0070196 |
The aggregation, arrangement and bonding together of a set of components to form the eukaryotic translation initiation factor 3 complex.
|
| meiotic attachment of telomere to nuclear envelope | GO_0070197 |
The meiotic cell cycle process in which physical connections are formed between telomeric heterochromatin and the nuclear envelope, facilitating bouquet formation.
|
| negative regulation of mRNA cap binding | GO_1905611 |
Any process that stops, prevents or reduces the frequency, rate or extent of mRNA cap binding.
|
| regulation of mRNA cap binding | GO_1905610 |
Any process that modulates the frequency, rate or extent of mRNA cap binding.
|
| negative regulation of mRNA binding | GO_1904572 |
Any process that stops, prevents or reduces the frequency, rate or extent of mRNA binding.
|
| positive regulation of mRNA cap binding | GO_1905612 |
Any process that activates or increases the frequency, rate or extent of mRNA cap binding.
|
| positive regulation of mRNA binding | GO_1902416 |
Any process that activates or increases the frequency, rate or extent of mRNA binding.
|
| regulation of mRNA binding | GO_1902415 |
Any process that modulates the frequency, rate or extent of mRNA binding.
|